Sana Biotechnology (SANA) vs SL Science (SLBT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Sana Biotechnology (SANA) has outperformed SL Science (SLBT) over the past year, losing 38.4% versus a loss of 85.3%. Sana Biotechnology is the larger company by market cap ($853.2 million vs $852.4 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SANA | SLBT |
|---|---|---|
| Share price | $2.85 | $1.52 |
| Market cap | $853.18M | $852.35M |
| 1-day change | +2.15% | 0.00% |
| YTD return | -31.45% | -85.59% |
| 1-year return | -38.41% | -85.32% |
| 5-year return | -86.58% | — |
| EPS (TTM) | $-0.76 | $-0.01 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.55 | $14.50 |
| 52-week low | $2.61 | $1.42 |
| Distance from 52-week high | -56.49% | -89.52% |
| Analyst consensus | none | — |
| Avg. price target upside | +195.79% | — |
| Average volume | 3.13M | 80.48K |
| Shares outstanding | 299.36M | 560.76M |
| Employees | 142 | 14 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SANA has outperformed SLBT by 46.9 percentage points over the past year.
About Sana Biotechnology
SANA stock →Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 142 employees
About SL Science
SLBT stock →SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 14 employees
SANA vs SLBT FAQ
Which is bigger, Sana Biotechnology or SL Science?
Sana Biotechnology (SANA) is larger, with a market capitalization of $853.18M compared with $852.35M for SL Science (SLBT).
Which stock has performed better over the past year, SANA or SLBT?
SANA returned -38.41% over the past 12 months, compared with -85.32% for SLBT (price return, excluding dividends). Past performance does not predict future results.
Are Sana Biotechnology and SL Science in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.